Clinical, Laboratory, and Treatment Characteristics of Seropositive and Seronegative Rheumatoid Arthritis: A Real-World Cohort Study
New Trends in Medicine Sciences · 29.10.2026 · 7 (3) · 116-125
DOI: 10.56766/ntms.2038514 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift New Trends in Medicine Sciences, online erschienen am 29.10.2026. Verfasst von Nihal Lermi und 1 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Seropositive and seronegative rheumatoid arthritis (RA) are increasingly recognized as clinically and biologically distinct disease subsets, yet comparative real-world data remain limited. We aimed to compare the sociodemographic, clinical, laboratory, and treatment characteristics of patients with seropositive and seronegative RA. This retrospective, single-center study included 559 patients with RA followed between September 2023 and May 2025. Seropositivity was defined as rheumatoid factor and/or anti-cyclic citrullinated peptide antibody (anti-CCP) positivity. Sociodemographic, clinical, laboratory, and treatment characteristics were compared between seropositive and seronegative patients. Of 559 patients, 446 (79.8%) were seropositive and 113 (20.2%) were seronegative. Disease duration was significantly longer in seropositive patients (p
Förderung
- None
Zitieren
APA
Lermi, N., & Garip, E. (2026). Clinical, Laboratory, and Treatment Characteristics of Seropositive and Seronegative Rheumatoid Arthritis: A Real-World Cohort Study. New Trends in Medicine Sciences, 7(3), 116-125. https://doi.org/10.56766/ntms.2038514
Vancouver
Lermi N, Garip E. Clinical, Laboratory, and Treatment Characteristics of Seropositive and Seronegative Rheumatoid Arthritis: A Real-World Cohort Study. New Trends in Medicine Sciences. 2026;7(3):116-125. doi:10.56766/ntms.2038514
BibTeX
@article{Lermi2026,
author = {Lermi, Nihal and Garip, Eyyüp},
title = {Clinical, Laboratory, and Treatment Characteristics of Seropositive and Seronegative Rheumatoid Arthritis: A Real-World Cohort Study},
journal = {New Trends in Medicine Sciences},
year = {2026},
volume = {7},
number = {3},
pages = {116--125},
doi = {10.56766/ntms.2038514}
}
EUVIMED